Towercrest Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$2.77M |
| 2 |
Invesco Emerging Markets Sovereign Debt ETF
PCY
|
+$2.6M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$1.95M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.89M |
| 5 |
Restaurant Brands International
QSR
|
+$1.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$3.82M |
| 2 |
iShares Floating Rate Bond ETF
FLOT
|
+$3.13M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$2.69M |
| 4 |
iShares Core Dividend Growth ETF
DGRO
|
+$2.17M |
| 5 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.11% |
| 2 | Financials | 1.01% |
| 3 | Communication Services | 0.79% |
| 4 | Healthcare | 0.52% |
| 5 | Consumer Discretionary | 0.27% |
Similar funds
Towercrest Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Towercrest Capital Management held 85 positions worth $382M, up 15% from $333M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Towercrest Capital Management's Q2 2020 filing shows 7 new, 40 increased, 25 reduced and 8 closed positions. Its largest new stake was Restaurant Brands International: 35,300 shares worth $268K. The largest sale was State Street SPDR Bloomberg Investment Grade Floating Rate ETF, an estimated $3.82M.
By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.8% a quarter earlier, followed by Financials and Communication Services.
- Towercrest Capital Management's largest Q2 2020 buy was Restaurant Brands International: 35,300 shares worth $268K.
- Towercrest Capital Management added most to Schwab US Large- Cap ETF in Q2 2020, an estimated $2.77M increase.
- Towercrest Capital Management's biggest Q2 2020 reduction was State Street SPDR Bloomberg Investment Grade Floating Rate ETF, cutting an estimated $3.82M.
- Towercrest Capital Management fully exited Iovance Biotherapeutics in Q2 2020, selling an estimated $748K.
- Towercrest Capital Management's ten largest holdings make up 47% of its $382M portfolio in Q2 2020.
- Towercrest Capital Management opened 7 new positions and closed 8 in Q2 2020.
- Towercrest Capital Management's portfolio value rose 15% quarter-over-quarter to $382M.
Based on Towercrest Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.